Article Details

FDA 2024 analysis: Small molecule resilience & oncology rebounds

Retrieved on: 2024-12-30 21:26:10

Tags for this article:

Click the tags to see associated articles and topics

FDA 2024 analysis: Small molecule resilience & oncology rebounds. View article details on hiswai:

Excerpt

Monoclonal antibodies gradually gain market share. mAbs may still trail small molecules in overall approvals, but their year-over-year climb is ...

Article found on: www.drugdiscoverytrends.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo